Skip to content

KZIA

Kazia Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$10.39
−4.33%
Ask drillr

Margins

Gross margin
100.0%
EBITDA margin
EBIT margin
Net margin
FCF margin
-48.0%
Return on equity
-31.4%
Return on assets
-39.0%
Return on invested capital
0.00x
Asset turnover
-$9.4M
Cash from operations
$3.52
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025